氏病中的骨参与:来自北非注册表的数据
Zeineb Meddeb1, Nour Ben Younes2, Houssem Abida2
1Faculty of Medicine of Tunis, University of Tunis El Manar, 1068 Tunis, Tunisia; Internal Medicine Department, Mongi Slim University Hospital, Tunis, Tunisia; Laboratory of Genetics, Immunology, and Human Pathology, Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.
氏病 (GD) 经常涉及骨,有65%的患者显示骨参与. 虽然像酶替代疗法 (ERT) 和基质减少疗法 (SRT) 这样的疗法显示出希望,但延迟诊断阻碍了有效的治疗.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
背景情况:
- 氏病 (Gaucher disease,GD) 是由于葡萄糖大脑酶缺乏而引起的,导致葡萄糖大脑酶的积累.
- 骨参与是高氏病的一个常见的全身表现.
- 评估骨干干涉 (BI) 和治疗影响对于管理GD患者至关重要.
研究的目的:
- 评估Gaucher病 (GD) 骨干干涉 (BI) 的患病率和特征.
- 评估酶替代疗法 (ERT) 和基质减少疗法 (SRT) 对GD患者骨健康的影响.
主要方法:
- 分析了突尼斯GD注册表中的74名患者的数据.
- 用骨X射线,MRI和骨矿物密度扫描来评估骨参与.
- 在最后的随访中评估了ERT和SRT的治疗结果.
主要成果:
- 在65%的GD患者中观察到骨参与 (BI),表现为骨疼痛,形,形病变,骨髓缩和骨髓透.
- 骨矿物质密度显示,14%的患者患有骨质疏松症,35%的患者患有骨质疏松症.
- 疗法显示出改善骨疼痛和骨密度的趋势,但统计学意义受到小样本大小的限制.
结论:
- 骨干涉是高希氏病的一个非常普遍的并发症.
- 特定的GD疗法表明了骨健康指标的潜在积极趋势.
- 迟到的诊断和有限的治疗机会在管理GD,特别是骨并发症方面带来了重大挑战.
更多相关视频
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
相关概念视频
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Chronic Pancreatitis II: Collaborative Care
Assessment:
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Lysosomal Hydrolases
